| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 349.233 | 319.193 | 350.886 | 317.748 | 369.869 | 176.344 | 394.382 | 249.386 | 208.501 | 174.482 |
| Total Income - EUR | 337.738 | 277.633 | 366.149 | 406.455 | 394.909 | 411.371 | 339.479 | 271.140 | 170.301 | 222.374 |
| Total Expenses - EUR | 329.992 | 267.953 | 348.127 | 401.683 | 390.851 | 409.428 | 336.264 | 347.188 | 296.138 | 236.649 |
| Gross Profit/Loss - EUR | 7.746 | 9.680 | 18.022 | 4.772 | 4.058 | 1.943 | 3.216 | -76.048 | -125.837 | -14.275 |
| Net Profit/Loss - EUR | 6.328 | 8.115 | 6.274 | 2.254 | 1.239 | 989 | 1.273 | -77.873 | -127.585 | -18.217 |
| Employees | 2 | 3 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 |
Check the financial reports for the company - Aliban Company Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.223 | 255.402 | 295.388 | 408.411 | 337.731 | 270.068 | 203.863 | 144.093 | 107.989 | 71.918 |
| Current Assets | 335.249 | 345.128 | 335.212 | 445.692 | 470.992 | 677.832 | 692.752 | 639.209 | 734.686 | 685.005 |
| Inventories | 179.072 | 174.868 | 214.952 | 298.949 | 377.240 | 618.662 | 612.132 | 584.363 | 535.135 | 530.282 |
| Receivables | 155.173 | 164.265 | 104.131 | 104.362 | 69.500 | 56.280 | 79.831 | 52.592 | 157.206 | 153.596 |
| Cash | 1.004 | 5.995 | 16.129 | 42.380 | 24.253 | 2.889 | 789 | 2.255 | 42.345 | 1.126 |
| Shareholders Funds | 9.341 | 11.097 | 9.205 | 5.132 | 6.271 | 7.141 | 8.255 | -69.592 | -48.838 | -72.220 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 332.132 | 610.432 | 644.358 | 875.179 | 819.848 | 956.870 | 897.419 | 858.313 | 896.373 | 833.976 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "111 - 111" | |||||||||
| CAEN Financial Year |
111
|
|||||||||
Comments - Aliban Company Srl